Australian comedian Dave Hughes has voiced strong criticism regarding reports that Erin Patterson, convicted in the deaths of three family members by poisonous mushrooms, has been prescribed the weight-loss drug Ozempic while incarcerated. Patterson, 51, is currently held at the Dame Phyllis Frost Centre in Melbourne, awaiting the outcome of her appeal against a sentence of at least 33 years. She was found guilty of murdering her former in-laws, Don and Gail Patterson, and Gail’s sister, Heather Wilkinson, after they consumed death cap mushrooms in beef Wellingtons at her Leongatha home in July 2023. Heather’s husband, Ian Wilkinson, survived the poisoning but was critically ill.
Controversy Over Inmate Healthcare Access
The news of Patterson’s prescription for Ozempic, a drug often used for weight management and type 2 diabetes treatment, has ignited public debate. Reports suggest the prescription was approved due to her isolation and limited exercise opportunities within the prison. A source reportedly told the Herald Sun that prison staff safety concerns are being overshadowed by management’s focus on a convicted murderer’s weight.
Hughes expressed his disbelief, stating, “She’s in solitary confinement. She’s not trying to keep away from the buffet on a cruise.” He suggested alternative methods for weight loss within the prison, humorously remarking, “Just ask for less food through the flap, Erin. Or, if you really want to lose weight, just ask them to make your special beef Wellington. I think the weight would fall off pretty quick then.”
Ozempic Prescription Policies in Prisons
Ozempic, while costing approximately $134 per month, is heavily subsidized under Australia’s Pharmaceutical Benefits Scheme for eligible patients, reducing the out-of-pocket cost to around $25. Unsubsidized alternatives like Mounjaro can range from $285 to $700 monthly. According to the Department of Justice and Community Safety, inmate access to such medications is contingent upon medical advice, with prescriptions issued by clinicians only when there is a clear medical necessity, such as preventing serious conditions like type 2 diabetes.
During her trial, Patterson had disclosed a long-standing struggle with binge eating and body image issues. These details emerged as she explained consuming cake after the fatal meal, subsequently vomiting. Her defense during the trial also touched upon these personal challenges.
Legal Proceedings and Appeals
Patterson has lodged an appeal against her conviction on seven grounds, including claims of a substantial miscarriage of justice during her 11-week trial, citing the exclusion of mushroom-related photographs as a key issue. Simultaneously, the Director of Public Prosecutions has appealed the sentence length, arguing it was too lenient and seeking a full life sentence without parole. The decision on these cross-appeals is pending from Justices Stephen McLeish, Lesley Taylor, and Peter Kidd.
Precedent for Inmate Medication Access
Patterson is not the first inmate to receive Ozempic. Alicia Schiller, serving a 16-year sentence for murder, has also been approved for taxpayer-funded Ozempic injections. Schiller was convicted of killing her housemate in 2014 and reportedly gained weight in prison. Reports indicated Schiller had transformed her cell into a “candy shop,” consuming significant amounts of snacks and sugary drinks. Her victim’s mother criticized the decision, calling it “absolutely ridiculous” and a waste of taxpayer funds, suggesting Schiller should manage her diet independently.
Victorian Minister Nick Staikos has previously defended the provision of weight-loss medications to inmates, framing it as a clinical decision aimed at preventing serious illnesses. He argued that such preventative healthcare measures could ultimately save taxpayer money in the long run by averting more costly health complications.
Conclusion
The prescription of Ozempic to Erin Patterson while in prison has sparked considerable public outcry and debate over inmate healthcare priorities and the allocation of public funds. While authorities maintain that such prescriptions are based on medical necessity and clinician recommendations, figures like Dave Hughes and the families of victims question the appropriateness of using taxpayer-subsidized medication for individuals convicted of serious crimes, especially when contrasted with broader societal needs and the costs involved.
